- $4.55bn
- $11.71bn
- $1.41bn
- 65
- 43
- 94
- 75
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,202 | 1,209 | 1,257 | 1,273 | 1,411 |
Cost of Revenue | |||||
Gross Profit | 869 | 874 | 943 | 966 | 1,060 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 921 | 922 | 961 | 933 | 1,023 |
Operating Profit | 281 | 287 | 297 | 340 | 388 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 145 | 125 | 195 | 177 | 246 |
Provision for Income Taxes | |||||
Net Income After Taxes | 104 | 88 | 142 | 122 | 187 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 211 | 151 | 143 | 156 | 259 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 211 | 151 | 143 | 156 | 259 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.02 | 3.51 | 1.91 | 3.78 | 4.59 |
Dividends per Share |